Attached files

file filename
EX-32.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10q0618ex32ii_actiniumpharm.htm
EX-31.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10q0618ex31ii_actiniumpharm.htm
EX-31.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10q0618ex31i_actiniumpharm.htm
EX-16.1 - LETTER OF GBH CPAS, PC TO THE SECURITIES AND EXCHANGE COMMISSION DATED AUGUST 9, - Actinium Pharmaceuticals, Inc.f10q0618ex16-1_actinium.htm
EX-10.2 - EMPLOYMENT AGREEMENT, DATED AUGUST 8, 2018, BETWEEN STEVE O'LOUGHLIN AND ACTINIU - Actinium Pharmaceuticals, Inc.f10q0618ex10-2_actinium.htm
EX-10.1 - EMPLOYMENT AGREEMENT, DATED AUGUST 8, 2018, BETWEEN SANDESH SETH AND ACTINIUM PH - Actinium Pharmaceuticals, Inc.f10q0618ex10-1_actinium.htm
EX-3.1 - AMENDED AND RESTATED BYLAWS OF ACTINIUM PHARMACEUTICALS, INC., DATED AUGUST 8, 2 - Actinium Pharmaceuticals, Inc.f10q0618ex3-1_actinium.htm
10-Q - QUARTERLY REPORT - Actinium Pharmaceuticals, Inc.f10q0618_actiniumpharma.htm

Exhibit 32.1

  

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Actinium Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2018  as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sandesh Seth, Chairman & CEO of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
   
2. The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: August 9, 2018 By: /s/ Sandesh Seth
    Sandesh Seth
   

Chairman & CEO

(Duly Authorized Officer and

Principal Executive Officer)